Skip to main content
Retour
Watch Compare

Evolent Health, Inc.

Qualité des données : 100%
EVH
NYSE Services Engineering & Management Services
2,33 €
▼ 0,11 € (-4,51%)
Cap. Boursière: 269,05 M
Prix
2,41 €
Cap. Boursière
269,05 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue grew 19,90% annually over 5 years — strong growth
Generating 38,84 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 46,46%

Croissance

Revenue Growth (5Y)
19,90%
Au-dessus de la moyenne du secteur (3,99%)
Revenue (1Y)-26,56%
Earnings (1Y)N/A
FCF Growth (3Y)-47,81%

Qualité

Return on Equity
-61,50%
En dessous de la moyenne du secteur (-15,95%)
ROIC-15,79%
Net Margin-28,49%
Op. Margin-21,86%

Sécurité

Debt / Equity
1,26
Au-dessus de la moyenne du secteur (0,39)
Current Ratio1,33
Interest Coverage-7,14

Valorisation

PE (TTM|NTM|2027)
-0,50 | 5,27 | 5,46
Au-dessus de la moyenne du secteur (-1,17)
P/B Ratio0,32
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (515 pairs)
Métrique Action Médiane du Secteur
P/E -0,5 -1,2
P/B 0,3 1,4
ROE % -61,5 -16,0
Net Margin % -28,5 -18,3
Rev Growth 5Y % 19,9 4,0
D/E 1,3 0,4

Objectif de Cours des Analystes

14 analystes
Buy
Actuel
2,33 €
+122.3%
Objectif
5,18 €
3,00 €
5,00 €
8,00 €
Prévisions
P/E Prévisionnel 5,27
BPA Prévisionnel 0,44 €
Croissance BPA (est.) +157,4%
CA Est. 2,88 B

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 0,44 €
0,30 € – 0,73 €
 2,88 B 11
FY2026 0,17 €
0,10 € – 0,35 €
 2,49 B 10

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 0,05 € 0,08 € +62,7%
Q32025 0,10 € 0,05 € -51,2%
Q22025 0,08 € -0,10 € -223,3%
Q12025 0,10 € 0,06 € -37,7%

ETFs Holding This Stock

SSETX SSETX
0,71% weight
SSYGX SSYGX
0,71% weight
RUDAX RUDAX
0,54% weight
BOSCX BOSCX
0,54% weight
BOSYX BOSYX
0,54% weight
STSVX STSVX
0,54% weight
MXMTX MXMTX
0,38% weight
FSCC logo FSCC Federated Hermes MDT Small Cap Core ETF
0,20% weight
OASGX OASGX
0,11% weight
OCSGX OCSGX
0,11% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -26,56% Revenue Growth (3Y) 83,69%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 19,90% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,88 B Net Income (TTM) -534,51 M
ROE -61,50% ROA -21,75%
Gross Margin N/A Operating Margin -21,86%
Net Margin -28,49% Free Cash Flow (TTM) 38,84 M
ROIC -15,79% FCF Growth (3Y) -47,81%
Safety
Debt / Equity 1,26 Current Ratio 1,33
Interest Coverage -7,14 Asset Turnover 0,76
Working Capital 140,17 M Tangible Book Value -856,84 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,50 Forward P/E 5,27
P/B Ratio 0,32 P/S Ratio 0,14
PEG Ratio N/A Forward PEG 0,03
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0,09 Fwd Earnings Yield 18,98%
FCF Yield 14,44%
Market Cap 269,05 M Enterprise Value 1,21 B
Per Share
EPS (Diluted TTM) -5,07 Revenue / Share 16,81
FCF / Share 0,35 OCF / Share 0,35
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion -7,27%
SBC-Adj. FCF -12,92 M Growth Momentum -46,46

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,88 B 2,55 B 556,06 M 382,43 M 907,96 M
Net Income -534,51 M -61,62 M -113,04 M -19,16 M -9,81 M
EPS (Diluted) -5,07 -0,81 -1,28 -0,20 -0,44
Gross Profit — — — — —
Operating Income -410,14 M -40,49 M -71,21 M 3,64 M -42,41 M
EBITDA — — — — —
R&D Expenses — — — — 15,50 M
SG&A Expenses 303,87 M 263,05 M 358,11 M 269,27 M 219,50 M
D&A 115,85 M 118,37 M 123,42 M 67,20 M 60,04 M
Interest Expense 57,47 M 24,72 M 54,21 M 15,57 M 25,43 M
Income Tax -126 000,0 -1,41 M -89,37 M -43,38 M 483 000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,90 B 2,54 B 2,68 B 1,82 B 1,42 B
Total Liabilities 1,48 B 1,35 B 1,43 B 957,88 M 725,83 M
Shareholders' Equity 415,19 M 1,00 B 1,07 B 859,42 M 693,63 M
Total Debt 970,54 M 661,99 M 597,05 M 412,99 M 215,68 M
Cash & Equivalents 151,86 M 104,20 M 192,83 M 188,20 M 266,28 M
Current Assets 506,37 M 607,12 M 683,67 M 478,05 M 523,96 M
Current Liabilities 385,26 M 715,50 M 674,24 M 433,44 M 445,49 M